Personalized Medicine

Papers
(The median citation count of Personalized Medicine is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Nanosensor Technologies and the Digital Transformation of Healthcare39
The Role of Metabolomics in Personalized Medicine for Diabetes36
Genetic and genomic learning needs of oncologists and oncology nurses in the era of precision medicine: a scoping review23
Pathology-Supported Genetic Testing Presents Opportunities for Improved Disability Outcomes in Multiple Sclerosis18
Gene detection of VDR BsmI locus and its approteins, genes and growthplication in rational drug use in patients with osteoporosis16
Successful Management of Delayed-Onset Adenosine Deaminase Deficiency with Novel Mutation15
Pharmacogenomics of Lipid-Lowering Agents: the Impact on Efficacy and Safety13
Ethics and Equity in Rare Disease Research and Healthcare12
A Sociogenomic Paradigm to Replace the Racial Paradigm11
The Integration of Personalized Medicine Into Health Systems: Progress and a Path Forward10
Efficacy of trastuzumab deruxtecan in treating HER2-low breast cancer leptomeningeal metastasis: a case report9
Healthcare Professionals’ Knowledge, Attitudes and Future Expectations Towards Personalized Medicine9
Aminoglycosides’ Dosage in Hematological Malignancies and Febrile Neutropenia: Extended Interval or Conventional Dosage?8
Seven non-Differentially Expressed ‘Dark Biomarkers’ Show Transcriptional Dysregulation in Chronic Lymphocytic Leukemia7
Development of a computer-based tool to obtain a family health history in Vietnam7
Lung cancer, platinum analog-based frontline treatment and pharmacogenetic limitations7
Role of precision nutrition in improving military performance7
European survey: citizens' attitudes on personalized medicine, genetic testing and health data sharing – design and delivery7
Clinician Perspectives on Communication and Implementation Challenges in Precision Oncology7
Helping the science speak for itself: lessons learned developing video summaries for a precision medicine and health disparities collaborative6
The correlation between the polymorphism of lysolecithin acyltransferase (MBOAT7) rs641738 and liver fibrosis6
Preliminary Radiogenomic Study of Hepatitis B Virus-Related Hepatocellular Carcinoma: Associations between MRI Features and Mutations6
Expanded Carrier Screening in Flanders (Belgium): An Online Survey on the Perspectives of Nonpregnant Reproductive-Aged Women6
Cost–effectiveness of Genetic-Based Screening Strategies for Maturity-Onset Diabetes of the Young6
Association of XRCC gene family and CDH1 gene polymorphisms with gastric cancer risk in a Chinese population6
Identification of novel variants of XPA and POLH/XPV genes in xeroderma pigmentosum patients in Vietnam5
Genetic Polymorphisms of very Important Pharmacogene Variants in the Chinese Lisu Population5
Looking Back Over 2023 and Welcome to the 21 st Issue of Personalized Medicine5
miR-369-3p Serves as Prognostic Factor and Regulates Cancer Progression of Hepatocellular Carcinoma5
Pharmacogenomic Considerations for Repurposing of Dexamethasone as a Potential Drug Against SARS-CoV-2 Infection5
miR-559 rs58450758 polymorphism is associated with colorectal cancer risk and prognosis in Chinese Han population5
Developing New Frameworks to Value Genomic Information: Accounting for Complexity5
Introduction of a single-nucleotide variant, rs16851030, into the ADORA1 gene increased cellular susceptibility to hypoxia5
Biomarker-Driven Immunotherapy for Precision Medicine in Prostate Cancer5
A Personalized Approach to Pancreatic Ductal Adenocarcinoma and its Application in Surgical Practice5
The Pharmacogenetics of Mycophenolate Mofetil in Tunisian Renal Transplant Patients5
Development of Competency-based Online Genomic Medicine Training (COGENT)4
Creating Accessible Spanish Language Materials for Clinical Sequencing Evidence-Generating Research Consortium Genomic Projects: Challenges and Lessons Learned4
HER2 in Gastric Adenocarcinoma: Where Do we Stand Today?4
Intelligent Health System for the Investigation of Consenting COVID-19 Patients and Precision Medicine4
Maternal and Placental ANRIL Polymorphisms and Preeclampsia Susceptibility4
Application of Transcriptomics and Proteomics in Pulmonary Arterial Hypertension4
Anna Karenina Principle in Personalized Treatment of Bladder Cancer According to Oncogram: Which Drug for which Patient?4
Corrigendum4
Genetic Predisposition for the Development of Lamotrigine-Induced Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis: a Systematic Review and Meta-Analysis4
Assessment of ADRB1 polymorphism in patients with acute coronary syndrome treated with ticagrelor and aspirin4
Long Noncoding RNA Polymorphisms and Hepatocellular Carcinoma and Pancreatic Cancer Risk4
Impact of MIR137HG  rs7554283 on susceptibility to high-altitude pulmonary edema in the Chinese population4
Gene expression profiling of peripheral blood in patients with steroid-induced osteonecrosis of the femoral head4
Microsatellite Instability Testing in Colorectal Patients with Lynch Syndrome: Lessons Learned from a Case Report and How to Avoid Such Pitfalls4
Pharmacogenomics education in China and the United States: advancing personalized medicine4
LncRNA Polymorphisms and Lung Cancer Risk3
The effect of genetic polymorphisms of AKT1 on PE susceptibility: a case-control study and insilico analysis3
Interindividual variability in diabetic patients’ response to opium poppy: an overview of impressive factors3
IL-6 Gene Polymorphism Predicts PEGylated IFN-α Treatment Response in Hepatitis B Surface Antigen-Positive Chronic Hepatitis B Patients3
Association Study of Genetic Polymorphisms in GABRD with Treatment Response and Dose in Methadone Maintenance Treatment3
Incidence of statin-associated muscle symptoms in patients taking statins with RYR1 or CACNA1S variants3
Developing the Workplace Learning Social System: considerations for genomics implementation and workforce preparedness3
Whole-exome sequencing reveals novel variants associated with abnormal uterine bleeding caused by copper intrauterine device3
Cost–effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries3
How people undergoing genomic sequencing interpret and react to varied secondary findings with limited actionability3
Identification of Dpyd Variants and Estimation of Uracil and Dihydrouracil in A Healthy Indian Population3
Machine-Learning Models Utilizing Cyp3A4*1G Show Improved Prediction of Hypoglycemic Medication in Type 2 Diabetes3
Cloud-based Digital Healthcare Development for Precision Medical Hospital Information System2
Prevalence of Protective Haplotypes of the SLCO1B1 Gene for Statin Transport in Mexican Populations2
The prognostic potential of long noncoding RNA XIST in cardiovascular diseases: a review2
The Use of Molecular Biomarker Tests: An Interview Study with Healthcare Providers about a Molecular Biomarker Test for Prostate Cancer2
Cost–effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK2
Exploring the usefulness of plasma level determination and pharmacogenetics for patients treated with clozapine2
Views on Genomic Research Result Delivery Methods and Informed Consent: A Review2
Diagnostic Utility of the 23-gene Expression Profile Test for an Atypical Intradermal Melanocytic Proliferation2
The rs2275738 variant of the adiponectin receptor 1 gene is associated with biopsy-proven nonalcoholic fatty liver disease2
Sino-European Science and Technology Collaboration on Personalized Medicine: Overview, Trends and Future Perspectives2
Long Noncoding RNA Polymorphisms in Gynecological Cancers2
Defining the Role of Pharmacists in Medication-Related Genetic Counseling2
Sars-Cov-2 Variant Identification Using a Genome Tiling Array and Genotyping Probes2
Conference Report: NHGRI Research Training and Career Development Annual Meeting2
Revolutionizing personalized cancer treatment: the synergy of next-generation sequencing and CRISPR/Cas92
COVID-19 Telehealth Preparedness: a Cross-Sectional Assessment of Cardiology Practices in the USA1
Targeting Molecular Alterations in Non-Small-Cell Lung Cancer: What’s Next?1
Budget Impact and Transferability of Cost–effectiveness of DPYD Testing in Metastatic Breast Cancer in Three Health Systems1
HEcoPerMed, Personalized Medicine from a Health Economic Perspective: Lessons Learned and Potential Opportunities Ahead1
Challenges and Opportunities in Building a Health Economic Framework for Personalized Medicine in Oncology1
Personalized approach in arrhythmology by genetic-based data: a case report1
MiR-455-5p Serves as a Biomarker of Atherosclerosis and Inhibits Vascular Smooth Muscle Cell Proliferation and Migration1
Personalized medicine in colorectal cancer: a comprehensive study of precision diagnosis and treatment1
Refining Personalized Diagnosis, Treatment and Exploitation of Hypothyroidism Related to Solid Nonthyroid Cancer1
miR-516a-3P, a Potential Circulating Biomarker in Hepatocellular Carcinoma, Correlated with rs738409 Polymorphism in PNPLA31
Risk of Polymyxin B-Induced acute Kidney Injury with a Non Adjusted Dose Versus Adjusted Dose Based on Renal Function1
Institutionalization of Personalized Medicine in India: Analysis of Research Trends and Government Interventions1
State-of-the-art knowledge on the regulation of advanced therapy medicinal products1
Low Rate of Complications in Nipple-Sparing Mastectomy for Patients with BRCA1 and BRCA2 Mutation1
Evaluating the Quality of the Economic Evidence in Colorectal Cancer Genomics Studies1
Clinical Significance of Serum miR-101-3p Expression in Patients with Neonatal Sepsis1
Association of NQO1Pro187Ser Polymorphism with Clinical Outcomes and Survival of Lung Cancer Patients Treated with Platinum Chemotherapy1
Artificial Intelligence in Healthcare: a Primer for Medical Education in Radiomics1
Developing and Validating Noninvasive Prenatal Testing for de novo Autosomal Dominant Monogenic Diseases in Vietnam1
Association between PRNCR1 , PAX8AS1 , MEG3 , and PTENP1 gene polymorphisms 1
Technological advances in clinical individualized medication for cancer therapy: from genes to whole organism1
Impact of CYP2C9*2 and *3 Polymorphisms on Valproate-Associated Adverse Drug Reactions in Individuals living with Epilepsy: a Case–control1
A Real-World Analysis of Tyrosine Receptor Kinase Inhibitor-Related Toxicities in Cancer Treatment1
Knowledge, attitudes and practices of Egyptian healthcare professionals toward therapeutic drug monitoring service as a principal component of personalized medicine1
Content Highlights of the Year: a Look Over 2022 at Personalized Medicine1
CYP2D6 Genotyping and the Clinical Impact on Outcomes in Breast Cancer Tamoxifen-Treated Patients1
0.036699056625366